Mechanism of Action: Cytochrome P450 2C19 Inducers
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 2C19 Inducers
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 078115-003 | Mar 31, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Umedica | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216594-001 | Aug 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Epic Pharma Llc | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216235-001 | Mar 2, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Taro Pharm Inds | CARBAMAZEPINE | carbamazepine | TABLET, CHEWABLE;ORAL | 075687-002 | Jul 29, 2002 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Apotex Inc | CARBAMAZEPINE | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 078986-002 | Nov 25, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Cspc Ouyi | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 213311-003 | Apr 13, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |